Opportunity ID: 320413

General Information

Document Type: Grants Notice
Funding Opportunity Number: PAR-19-367
Funding Opportunity Title: Maximizing Investigators’ Research Award (R35 – Clinical Trial Optional)
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Grant
Category of Funding Activity: Health
Category Explanation:
Expected Number of Awards:
Assistance Listings: 93.859 — Biomedical Research and Research Training
Cost Sharing or Matching Requirement: No
Version: Synopsis 1
Posted Date: Sep 09, 2019
Last Updated Date: Sep 09, 2019
Original Closing Date for Applications: May 17, 2022
Current Closing Date for Applications: May 17, 2022
Archive Date: Jun 22, 2022
Estimated Total Program Funding:
Award Ceiling:
Award Floor:

Eligibility

Eligible Applicants: Native American tribal organizations (other than Federally recognized tribal governments)
Public housing authorities/Indian housing authorities
Special district governments
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Others (see text field entitled “Additional Information on Eligibility” for clarification)
Native American tribal governments (Federally recognized)
City or township governments
Independent school districts
Private institutions of higher education
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Public and State controlled institutions of higher education
Small businesses
State governments
For profit organizations other than small businesses
County governments
Additional Information on Eligibility: Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed.

Additional Information

Agency Name: National Institutes of Health
Description: The Maximizing Investigators’ Research Award (MIRA) provides support for the program of research in an investigator’s laboratory that is within the mission of NIGMS. The goal of MIRA is to increase the efficiency and efficacy of NIGMS funding. It is anticipated that this program will: Increase the stability of funding for NIGMS-supported investigators, which could enhance their ability to take on ambitious scientific projects and approach problems more creatively; Increase flexibility for investigators to follow important new research directions within the NIGMS mission as opportunities arise, rather than being bound to specific aims proposed in advance of the studies; More widely distribute funding among the nation’s highly talented and promising investigators to increase overall scientific productivity and the chances for important breakthroughs; Reduce the time spent by researchers writing and reviewing grant applications, allowing them to spend more time conducting research; Enable investigators to devote more time and energy to mentoring trainees in a more stable research environment. This FOA allows both new applications from eligible NIGMS-funded investigators and renewal applications from current established and early-stage MIRA grantees.
Link to Additional Information: http://grants.nih.gov/grants/guide/pa-files/PAR-19-367.html
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV
Email:FBOWebmaster@OD.NIH.GOV

Version History

Version Modification Description Updated Date

Folder 320413 Full Announcement-PAR-19-367 -> PAR-19-367-Full-Announcement.pdf

Packages

Agency Contact Information: NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV
Email: FBOWebmaster@OD.NIH.GOV
Who Can Apply: Organization Applicants

Assistance Listing Number Competition ID Competition Title Opportunity Package ID Opening Date Closing Date Actions
FORMS-E Use for due dates on or before May 24, 2020 PKG00254699 Dec 17, 2019 Jun 30, 2020 View
FORMS-F Use for due dates on or before January 24, 2022 PKG00260248 Dec 17, 2019 Jan 24, 2022 View
FORMS-G Use for due dates on or after January 25, 2022 PKG00271868 Feb 02, 2022 May 17, 2022 View

Package 1

Mandatory forms

320413 RR_SF424_2_0-2.0.pdf

320413 PHS398_CoverPageSupplement_4_0-4.0.pdf

320413 RR_OtherProjectInfo_1_4-1.4.pdf

320413 PerformanceSite_2_0-2.0.pdf

320413 RR_KeyPersonExpanded_2_0-2.0.pdf

320413 RR_Budget10_1_4-1.4.pdf

320413 PHS398_ResearchPlan_4_0-4.0.pdf

Optional forms

320413 RR_SubawardBudget10_30_1_4-1.4.pdf

320413 PHS_AssignmentRequestForm_2_0-2.0.pdf

Package 2

Mandatory forms

320413 RR_SF424_2_0-2.0.pdf

320413 PHS398_CoverPageSupplement_5_0-5.0.pdf

320413 RR_OtherProjectInfo_1_4-1.4.pdf

320413 PerformanceSite_2_0-2.0.pdf

320413 RR_KeyPersonExpanded_2_0-2.0.pdf

320413 RR_Budget10_1_4-1.4.pdf

320413 PHS398_ResearchPlan_4_0-4.0.pdf

320413 PHSHumanSubjectsAndClinicalTrialsInfo_2_0-2.0.pdf

Optional forms

320413 RR_SubawardBudget10_30_1_4-1.4.pdf

320413 PHS_AssignmentRequestForm_3_0-3.0.pdf

Package 3

Mandatory forms

320413 RR_SF424_5_0-5.0.pdf

320413 PHS398_CoverPageSupplement_5_0-5.0.pdf

320413 RR_OtherProjectInfo_1_4-1.4.pdf

320413 PerformanceSite_4_0-4.0.pdf

320413 RR_KeyPersonExpanded_4_0-4.0.pdf

320413 RR_Budget10_3_0-3.0.pdf

320413 PHS398_ResearchPlan_4_0-4.0.pdf

320413 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf

Optional forms

320413 RR_SubawardBudget10_30_3_0-3.0.pdf

320413 PHS_AssignmentRequestForm_3_0-3.0.pdf

2025-07-09T08:57:50-05:00

Share This Post, Choose Your Platform!

About the Author: